文献速递慢性肾脏病

管理共存肥胖与慢性肾脏病的障碍与机遇:美国国家肾脏基金会与肥胖学会联合主办的科学研讨会报告

Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society.
PubMed 文献 · Am J Kidney Dis · 2022-10-21

美国国家肾脏基金会(NKF)与肥胖学会(TOS)于2021年4月联合主办多学科国际研讨会,探讨成人慢性肾脏病(CKD)合并肥胖的理解与管理。与会专家识别了增加患者和提供者参与肥胖管理的策略,提出了肾脏病学家与肥胖医学专家合作的行动计划,并明确了研究机遇。研讨会结论为制定有效、科学、多学科的CKD患者肥胖管理方法奠定了基础。

要点

  • 肥胖是CKD及其不良结局的重要Contributor,有效治疗肥胖可带来益处。
  • 研讨会识别了增加患者和提供者参与肥胖管理的策略。
  • 提出了肾脏病学家与肥胖医学专家合作的行动计划及研究机遇。

核心结论

  • 研讨会结论为制定有效、科学、多学科的CKD患者肥胖管理方法奠定了基础。

研究设计与样本

  • 美国国家肾脏基金会(NKF)与肥胖学会(TOS)于2021年4月联合主办的多学科国际研讨会。
  • 与会者包括肾脏病、肥胖医学、内分泌学、糖尿病、减重/代谢外科、内镜、移植外科和营养学等领域的专家,以及肥胖合并CKD患者。

主要发现

  • 研讨会识别了增加患者和提供者参与肥胖管理的策略。
  • 研讨会提出了肾脏病学家与肥胖医学专家合作的行动计划。
  • 研讨会明确了解决肥胖与肾脏病相互作用知识缺口的研究机遇。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Friedman AN, Schauer PR, Beddhu S, et al. Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society. Am J Kidney Dis. 2022. PMID: 36280397. doi:10.1053/j.ajkd.2022.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。